INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 48m ago
HOUSE PTR8m ago
SEC 13F8m ago
ROBINHOOD CHAIN8m ago
SEC FORM 4/Grant or awardVerified data

Antonijevic Irina reported BHVN

Director · Biohaven Ltd. · Biohaven Ltd. — Stock Options (Right to buy)

Side
A
Value
—
Shares
68.7K
Price
—
Executed
Apr 28, 2026
Disclosed
Apr 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 28 executedApr 30, 2026 disclosed

BHVN · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

    No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BHVN

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Grant or award
    		A—
    68.7K sh
    		Apr 28, 2026Apr 30, 2026
    traded Apr 28, 2026
    		+2dSEC FORM 4

    Evidence

    12
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Gift
    		G—
    17.3K sh
    		Mar 17, 2026Mar 19, 2026
    traded Mar 17, 2026
    		+2dSEC FORM 4

    Evidence

    12
    MK
    Mehta KishanDirector
    BHVNBiohaven Ltd.
    Gift
    		G—
    17.3K sh
    		Mar 17, 2026Mar 19, 2026
    traded Mar 17, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,250 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CB
    Car BruceChief Scientific Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,750 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    2,500 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Tax withholding
    		F$11K
    1,117 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CB
    Car BruceChief Scientific Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,750 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    4,250 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BM
    Buten MatthewChief Financial Officer
    BHVNBiohaven Ltd.
    Tax withholding
    		F$26K
    2,594 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    17
    CB
    Car BruceChief Scientific Officer
    BHVNBiohaven Ltd.
    Tax withholding
    		F$24K
    2,381 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    21
    CC
    Clark George C.VP, Chief Accounting Officer
    BHVNBiohaven Ltd.
    Option exercise
    		M—
    2,500 sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    46
    BG
    Bailey GregoryDirector
    BHVNBiohaven Ltd.
    Open-market purchase
    		BUY$3.00M
    400.0K sh
    		Nov 13, 2025Nov 17, 2025
    traded Nov 13, 2025
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001926476-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Apr 28, 2026
    Published
    Apr 30, 2026
    Ingested by INSIDER
    Nov 5, 04:01 UTC
    Last re-read
    Nov 5, 04:01 UTC

    Extracted facts

    Filer
    Antonijevic Irina
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Biohaven Ltd. — Stock Options (Right to buy)
    Ticker
    BHVN
    Shares
    68.7K
    Price per share
    $0
    Execution date (reported)
    Apr 28, 2026
    Owned after transaction
    68.7K shares
    Days from execution to publication
    2

    What this establishes

    Antonijevic Irina filed this Form 4 reporting a grant or award of BHVN on Apr 28, 2026. It became public on Apr 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Antonijevic Irinacik:0001926476
    Issuer
    Biohaven Ltd.cik:0001935979

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.